184 Effects of elexacaftor/tezacaftor/ivacaftor therapy on lung clearance index and magnetic resonance imaging in patients with cystic fibrosis and one or two F508del alleles
S. Graeber, D. Renz, M. Stahl, S. Pallenberg, O. Sommerburg, L. Naehrlich, J. Berges, M. Dohna, F. Ringshausen, F. Doellinger, J. Röhmel, S. Hämmerling, S. Barth, C. Rückes-Nilges, M. Wielpütz, G. Hansen, J. Vogel-Claussen, B. Tümmler, M. Mall, A. Dittrich
Topics & Concepts
IvacaftorCystic fibrosisMedicineMagnetic resonance imagingInternal medicineRadiologyCystic fibrosis transmembrane conductance regulatorCystic Fibrosis Research AdvancesInhalation and Respiratory Drug DeliveryPediatric health and respiratory diseases